To award sbir phase I to intralytix
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93021C00034
- Awardee
-
Intralytix Inc. UEI HXUNCLKMHAP4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,797,717
Award facts
- Contract value 100% obligated
- $1,797,717.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 6 offers Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Columbia, MD 21046, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,498,045 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $0 | |
| Original award | $299,672 |
About this award
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with NIAID's broader mission and programs focused on infectious disease management and supporting biomanufacturing capabilities. This contract award does not have a set-aside designation and is a firm fixed-price definitive contract with a completion date of September 16, 2024.
Quick answers
Who was awarded contract 75N93021C00034?
75N93021C00034 was awarded to Intralytix Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 16, 2021.
How much is contract 75N93021C00034 worth?
The government has obligated $1,797,717 on 75N93021C00034.
Was contract 75N93021C00034 competed?
The extent of competition for 75N93021C00034 was not available for competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award